Login
Evidence Feed
About
Diagnostics
New
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
DRUG:
KUR-501
i
Other names:
KUR-501, CMD-501, CAR-NKT therapy, CAR.GD2-IL-15 NKTs, Chimeric antigen receptors natural killer T-cells (CAR-NKT) therapy, GINAKIT cells, GD2-CAR, GD2-CAR NKT cells, CAR-modified NKT-cell therapy
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Associations
News
Trials
Company:
Athenex, Baylor College of Medicine, Texas Children’s Hospital
Drug class:
GD2 ganglioside inhibitor
Related drugs:
‹
dinutuximab beta (2)
naxitamab-gqgk (1)
dinutuximab (1)
TRBS07 (0)
GD2-GD3 Vaccine (0)
GD2-SADA (0)
BCD-245 (0)
Hu14.18K322A (0)
APN301 (0)
GD2xCD3 (0)
dinutuximab beta (2)
naxitamab-gqgk (1)
dinutuximab (1)
TRBS07 (0)
GD2-GD3 Vaccine (0)
GD2-SADA (0)
BCD-245 (0)
Hu14.18K322A (0)
APN301 (0)
GD2xCD3 (0)
›
Associations
News
Trials
VERI cancer hierarchy
Reset Filters
^
^
×
Unlock More with VERI
Sign up to access premium content
Email *
Password *
Confirm Password *
I'm not a robot
Please register with your email ID.
×
Unlock More with VERI
Sign up to access premium content
Email *
Password *
Confirm Password *
I'm not a robot
Please register with your email ID.